Samsung and Mass General are studying whether Galaxy Watch8 data can help doctors monitor muscle loss during GLP-1 ...

Samsung Electronics and Boston-based Massachusetts General Hospital’s Diabetes Research Center are launching a clinical study to evaluate whether the Galaxy Watch8 can help adults beginning GLP-1 ...

The six-month clinical study will enroll 100 adults starting weight-loss drug therapy to test whether smartwatch data can ...

Samsung has launched a clinical study to explore how smartwatch data can mitigate muscle mass loss in adults receiving GLP-1 therapy.

Samsung is using the Galaxy Watch 8 to examine users of Ozempic and other GLP-1 weight-loss drugs and offer personalized ...

Samsung has teamed up with diabetes experts at Massachusetts General Hospital to see how Galaxy Watch 8 can help prevent muscle loss in GLP-1 patients.

Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat significantly less, leaving them vulnerable to nutritional deficiencies, ...